Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gillis

Showing results (381-390 of 427) with videos related to

Pageof 43
Sort By:
European Urology Open Science|November 5, 2021
Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II TrialMichal Mego, Katarina Rejlekova, Daniela Svetlovska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2022
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell TumorsDennis M Timmerman, Thomas F Eleveld, Sruthi Sriram, et al.
The Biochemical Journal|November 25, 2017
Reduced expression of cardiac ryanodine receptor protects against stress-induced ventricular tachyarrhythmia, but increases the susceptibility to cardiac alternansXiaowei Zhong, Alexander Vallmitjana, Bo Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
IgG Subclass-Dependent Pulmonary Antigen Retention during Acute IgG-Dependent Systemic Anaphylaxis in MiceBiliana Todorova, Ophélie Godon, Eva Conde, et al.
Cancer Cell International|August 11, 2020
Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemnessSilvia Schmidtova, Lambert C J Dorssers, Katarina Kalavska, et al.
CMAJ Open|January 26, 2021
Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot studyJohn A Sapp, Anne M Gillis, Amir AbdelWahab, et al.
Cancer Research|September 17, 2005
Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adultsAlan McIntyre, Brenda Summersgill, Beata Grygalewicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumorsFriedemann Honecker, Hendrik Wermann, Frank Mayer, et al.
Molecular Oncology|September 10, 2013
Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principleAd J M Gillis, Martin A Rijlaarsdam, Ronak Eini, et al.
Advances in Experimental Medicine and Biology|August 19, 2007
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumorsP Mathijs Voorhoeve, Carlos le Sage, Mariette Schrier, et al.
Pageof 43

Showing results (381-390 of 427) with videos related to

Sort By:
Pageof 43
European Urology Open Science|November 5, 2021
Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II TrialMichal Mego, Katarina Rejlekova, Daniela Svetlovska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2022
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell TumorsDennis M Timmerman, Thomas F Eleveld, Sruthi Sriram, et al.
The Biochemical Journal|November 25, 2017
Reduced expression of cardiac ryanodine receptor protects against stress-induced ventricular tachyarrhythmia, but increases the susceptibility to cardiac alternansXiaowei Zhong, Alexander Vallmitjana, Bo Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
IgG Subclass-Dependent Pulmonary Antigen Retention during Acute IgG-Dependent Systemic Anaphylaxis in MiceBiliana Todorova, Ophélie Godon, Eva Conde, et al.
Cancer Cell International|August 11, 2020
Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemnessSilvia Schmidtova, Lambert C J Dorssers, Katarina Kalavska, et al.
CMAJ Open|January 26, 2021
Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot studyJohn A Sapp, Anne M Gillis, Amir AbdelWahab, et al.
Cancer Research|September 17, 2005
Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adultsAlan McIntyre, Brenda Summersgill, Beata Grygalewicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumorsFriedemann Honecker, Hendrik Wermann, Frank Mayer, et al.
Molecular Oncology|September 10, 2013
Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principleAd J M Gillis, Martin A Rijlaarsdam, Ronak Eini, et al.
Advances in Experimental Medicine and Biology|August 19, 2007
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumorsP Mathijs Voorhoeve, Carlos le Sage, Mariette Schrier, et al.
Pageof 43